NYSE · SERVICES-MISC HEALTH & ALLIED SERVICES, NEC · LARGE CAP
Davita Inc. DVA
19 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$13.6B
▲ 6.5% vs FY2024
EPS · FY25
$9.84
Dividend / sh · FY25
—
Payout · FY25
0%
ROE · FY25
—
Net margin · FY25
5.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 13.6B
Revenue, FY2025 · full 19-year series below
Revenue
Net income
5 cents of every revenue dollar became profit this year.
Per share
USD 9.84
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
—
Return on equity, FY2025
ROE
Operating margin15.0%
Net margin5.5%
Return on assets4.3%
Returned to shareholders
USD 1.3B
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 1.3B
Share of profit175.2%
Consecutive raises—
USD 1.3B in buybacks — 175% of the year's profit, so the payout drew on cash built up earlier.
Growth
+3.4% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+5.5%
+3.4%
Net income
+10.0%
−0.7%
+10.7%
+4.2%
EPS, diluted
+18.9%
+9.3%
+22.9%
Returned to shareholders
+17.7%
−2.1%
+9.6%
+5.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.07B
Shares outstanding, FY2025
Change, 5 years−37.6%
Change, 10 years−67.3%
The share count shrank 38% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 17.5B
total assets, end of FY2025
Total assetsUSD 17.5B
EquityUSD -651.1M
CashUSD 676.4M
Gross debtUSD 10.2B
Net debtUSD 9.5B
Current ratio1.29×
Net debt stands at -1457% of equity.
History
19 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Revenue $B
13.6
12.8
12.1
11.6
11.6
11.6
11.4
10.7
10.1
9.7
·
·
·
·
·
·
·
·
·
Operating income $B
2.0
2.1
1.6
1.3
1.8
1.7
1.6
1.5
1.8
2.0
1.1
1.8
1.6
1.3
1.2
1.0
0.9
0.9
0.9
EBITDA $B
2.8
2.8
2.3
2.1
2.5
2.3
2.2
2.1
2.4
2.5
1.6
2.2
1.9
1.6
1.4
1.2
1.2
1.1
·
Income tax $B
0.3
0.3
0.2
0.2
0.3
0.3
0.3
0.3
0.3
0.4
0.2
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.2
Net income $B
0.7
0.9
0.7
0.6
1.0
0.8
0.8
0.2
0.7
0.9
0.3
0.7
0.6
0.5
0.5
0.4
0.4
0.4
0.4
EPS, diluted $
9.84
10.73
7.42
5.85
8.90
6.31
5.27
0.92
3.47
4.29
1.25
3.33
2.95
2.74
2.48
3.94
4.06
3.53
3.55
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
0
0
0
0
0
0
0
0
·
·
·
·
·
·
·
·
·
·
·
ROE %
·
159.1
78.2
76.4
91.5
44.0
27.8
3.8
14.2
18.5
5.4
15.1
15.5
18.2
23.2
19.7
21.7
21.2
·
Shares out B
0.07
0.08
0.09
0.09
0.10
0.11
0.13
0.17
0.18
0.19
0.21
0.22
0.21
0.21
0.09
0.10
0.10
0.10
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
55 of 55
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed